Biohaven (BHVN) Non Operating Income (2021 - 2026)
Biohaven (BHVN) reported Non Operating Income of $168000.0 for Q1 2026, down 65.92% on a YoY basis from $493000.0 in Q1 2025, and up 106.8% sequentially from -$2.5 million in Q4 2025.
Biohaven (BHVN) Non Operating Income (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of Non Operating Income data on file, last reported at $168000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 65.92% year-over-year to $168000.0; the trailing twelve-month figure through Mar 2026 stood at $7.7 million (down 78.45% YoY), and the FY2025 full-year result was $8.0 million, down 79.71% from the prior year.
- Non Operating Income rose to $168000.0 in Q1 2026, from -$2.5 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $17.8 million in Q3 2024 to a low of -$3.8 million in Q3 2025.
- A 5-year average of $4.5 million and a median of $3.7 million in 2024 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income tumbled 226.41% in 2022 and soared 205825.0% in 2023, its largest moves.
- Tracing BHVN's Non Operating Income over 5 years: stood at -$1.8 million in 2022, then surged by 521.27% to $7.7 million in 2023, then slumped by 59.5% to $3.1 million in 2024, then slumped by 178.76% to -$2.5 million in 2025, then surged by 106.8% to $168000.0 in 2026.
- Business Quant data shows BHVN's Non Operating Income at $168000.0 in Q1 2026, -$2.5 million in Q4 2025, and -$3.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 168,000.00 |
| Dec 31, 2025 | -2.47 Mn |
| Sep 30, 2025 | -3.84 Mn |
| Jun 30, 2025 | 13.82 Mn |
| Mar 31, 2025 | 493,000.00 |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 17.81 Mn |
| Jun 30, 2024 | 14.18 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | 7.74 Mn |
| Sep 30, 2023 | 4.69 Mn |
| Jun 30, 2023 | 5.84 Mn |
| Mar 31, 2023 | 8.23 Mn |
| Dec 31, 2022 | -1.84 Mn |
| Jun 30, 2022 | -67,000.00 |
| Mar 31, 2022 | -4,000.00 |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | -5,000.00 |